Lily Wound

Partner at DLA Piper

About the Expert

Lily Wound is a corporate attorney who advises companies in a wide range of complex commercial, licensing and other intellectual property-related transactions, with a focus on companies in the biotechnology, pharmaceutical and life sciences fields as well as companies in climate change.

Lily Wound, a partner in Goodwin’s Technology and Life Sciences group, has extensive experience representing pharmaceutical, biotechnology, and other life sciences companies in a wide range of complex commercial, corporate, and licensing transactions, including those involving gene therapy, gene editing, engineered cell therapy, and genomic testing. With broad knowledge of licensing and collaboration matters, Ms. Wound has worked on some of the most complex life sciences collaborations in the industry and has handled transactions at every stage of the life cycle of a life sciences product. In addition, her roster of domestic and international clients extends to the healthcare, healthcare information and technology, cosmetics, publishing, media, internet, software, and technology industries.

Ms. Wound joined Goodwin in 2019 from WilmerHale, where she served as counsel. She has also served as in-house counsel at Hearst Corporation, where she advised on all aspects of Hearst's businesses relating to healthcare information and technology, traditional media, new media, and digital media. Her responsibilities at Hearst included serving as general counsel for an evidence-based medical information and technology company and leading all complex transactions in the newspapers division.

ExpertisE

Meeting Location

• Virtual